ADAR1 Capital Management »

Screaming Eagle Acq Class A shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Screaming Eagle Acq Class A shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Screaming Eagle Acq Class A

Tip: Access up to 7 years of quarterly data

All positions including Screaming Eagle Acq Class A held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Screaming Eagle Acq Class A by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $321k 30k 10.70
2023-12-31 $318k 30k 10.60

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management